Gene · 494336
Papers3,170
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,170
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Colorectal cancer-derived extracellular vesicles: at the crossroads of the tumor microenvironment and gut microbiota. | Front Immunol | 2026 | 41727493 | PubTator, text mining | PubMed |
| Something Old, Something New, Something Borrowed… About the Placenta. | Epigenomes | 2026 | 41718403 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Overview of exosomal non-coding RNAs in cardiovascular disease using high throughput sequencing. | Eur J Pharmacol | 2025 | 42640698 | PubTator, text mining | PubMed |
| The AI-driven blueprint: decoding intervertebral disc repair mechanisms for intelligent biomaterial design. | Front Cell Dev Biol | 2025 | 41458159 | PubTator, text mining | PubMed |
| Identification of a Novel Salivary Four-miRNA Signature for Non-Invasive Diagnosis of Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2025 | 41373532 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
| miR-424 Targets AKT3 and PSAT1 and Has a Tumor-Suppressive Role in Human Colorectal Cancer [Retraction]. | Cancer Manag Res | 2025 | 41185640 | PubTator, text mining | PubMed |
| Retraction of: "LncRNA CASC15 inhibition relieves renal fibrosis in diabetic nephropathy through downregulating SP-A by sponging to miR-424". | Open Med (Wars) | 2025 | 41141932 | PubTator, text mining | PubMed |
| Exosome miRNA sorting controlled by RNA-binding protein-motif interactions. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132505 | PubTator, text mining | PubMed |
| Scientometric analysis of extracellular vesicles in vision science (up to 2024). | J Nanobiotechnology | 2025 | 41074034 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| Molecular and Genetic Markers for Malignant Melanoma: Implications for Prognosis and Therapy. | Dermatopathology (Basel) | 2025 | 40981345 | PubTator, text mining | PubMed |
| MiR-26b-5p mediates radioresistance and immunosuppression via targeting PRKCD in non-small cell lung cancer. | J Cancer Res Clin Oncol | 2025 | 40965741 | PubTator, text mining | PubMed |
| NUTM2A-AS1 as a potential key regulator in cancer: unraveling its ceRNA networks and impact on tumor biology. | Eur J Med Res | 2025 | 40903777 | PubTator, text mining | PubMed |
| The Crucial Role of Epigenetic Modifications in Wharton's Jelly Stem Cells. | Int J Mol Sci | 2025 | 40806302 | PubTator, text mining | PubMed |
| Diagnostic and prognostic significance of lncRNA THRIL in gestational diabetes mellitus and the regulation of trophoblastic function. | Ir J Med Sci | 2025 | 40788443 | PubTator, text mining | PubMed |
| Mechanisms and therapeutic strategies linking mesenchymal stem cells senescence to osteoporosis. | Front Endocrinol (Lausanne) | 2025 | 40761817 | PubTator, text mining | PubMed |
| Exploring microRNA targeting as a promising approach for solid tumor treatment. | Front Oncol | 2025 | 40761244 | PubTator, text mining | PubMed |
| Targeting Cis-regulatory elements for CRISPR-mediated transcriptional activation of the human MIR503HG locus. | Vascul Pharmacol | 2025 | 40653285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/494336/papers?page=2